Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masahiro Yamamura

Showing results (1-10 of 84) with videos related to

Pageof 9
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 24, 2007
[Monitoring of clinical course in TNF inhibitor treatment for rheumatoid arthritis--efficacy evaluation, adverse effect detection, and prediction of clinical response]Masahiro Yamamura
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 12, 2010
[Proteasome inhibitor]Masahiro Yamamura, Toshihiro Hirai, Yoshiyuki Yamaguchi
Nephron|December 18, 2001
Expression of Fc gamma receptor III (CD16) on monocytes during hemodialysis in patients with chronic renal failureNorikuni Kawanaka, Yoshio Nagake, Masahiro Yamamura, et al.
Anticancer Research|January 30, 2022
Republication: A Prospective Observational Study of Adoptive Immunotherapy for Cancer Using Zoledronate-Activated Killer (ZAK) Cells - An Analysis for Patients With Incurable Pancreatic CancerYoshiyuki Yamaguchi, Yousuke Katata, Makoto Okawaki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 16, 2015
[Current Cancer Immunotherapy Using Activated Lymphocytes - Do Lymphocytes Actually Recognize Cancer Cells ?]Yoshiyuki Yamaguchi, Yousuke Katata, Makoto Okawaki, et al.
Anticancer Research|April 30, 2016
A Prospective Observational Study of Adoptive Immunotherapy for Cancer Using Zoledronate-Activated Killer (ZAK) Cells - An Analysis for Patients with Incurable Pancreatic CancerYoshiyuki Yamaguchi, Yousuke Katata, Makoto Okawaki, et al.
Modern Rheumatology|April 20, 2006
Hypokalemic paralysis and osteomalacia secondary to renal tubular acidosis in a case with primary Sjögren's syndromeMasanori Kawashima, Tetsuki Amano, Yoshitaka Morita, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 9, 2020
[Case of Intestinal GIST with Long-Term Survival after Multidisciplinary Treatment, Including Surgical Resection for Liver Metastasis]Mio Uraoka, Toshimasa Okada, Yasuto Fujimoto, et al.
International Journal of Oncology|December 21, 2018
DKK3 knockdown confers negative effects on the malignant potency of head and neck squamous cell carcinoma cells via the PI3K/Akt and MAPK signaling pathwaysNaoki Katase, Shin-Ichiro Nishimatsu, Akira Yamauchi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 26, 2018
[Introduction]Yoshiyuki Yamaguchi, Yosuke Katata, Makoto Okawaki, et al.
Pageof 9

Showing results (1-10 of 84) with videos related to

Sort By:
Pageof 9
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 24, 2007
[Monitoring of clinical course in TNF inhibitor treatment for rheumatoid arthritis--efficacy evaluation, adverse effect detection, and prediction of clinical response]Masahiro Yamamura
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 12, 2010
[Proteasome inhibitor]Masahiro Yamamura, Toshihiro Hirai, Yoshiyuki Yamaguchi
Nephron|December 18, 2001
Expression of Fc gamma receptor III (CD16) on monocytes during hemodialysis in patients with chronic renal failureNorikuni Kawanaka, Yoshio Nagake, Masahiro Yamamura, et al.
Anticancer Research|January 30, 2022
Republication: A Prospective Observational Study of Adoptive Immunotherapy for Cancer Using Zoledronate-Activated Killer (ZAK) Cells - An Analysis for Patients With Incurable Pancreatic CancerYoshiyuki Yamaguchi, Yousuke Katata, Makoto Okawaki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 16, 2015
[Current Cancer Immunotherapy Using Activated Lymphocytes - Do Lymphocytes Actually Recognize Cancer Cells ?]Yoshiyuki Yamaguchi, Yousuke Katata, Makoto Okawaki, et al.
Anticancer Research|April 30, 2016
A Prospective Observational Study of Adoptive Immunotherapy for Cancer Using Zoledronate-Activated Killer (ZAK) Cells - An Analysis for Patients with Incurable Pancreatic CancerYoshiyuki Yamaguchi, Yousuke Katata, Makoto Okawaki, et al.
Modern Rheumatology|April 20, 2006
Hypokalemic paralysis and osteomalacia secondary to renal tubular acidosis in a case with primary Sjögren's syndromeMasanori Kawashima, Tetsuki Amano, Yoshitaka Morita, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 9, 2020
[Case of Intestinal GIST with Long-Term Survival after Multidisciplinary Treatment, Including Surgical Resection for Liver Metastasis]Mio Uraoka, Toshimasa Okada, Yasuto Fujimoto, et al.
International Journal of Oncology|December 21, 2018
DKK3 knockdown confers negative effects on the malignant potency of head and neck squamous cell carcinoma cells via the PI3K/Akt and MAPK signaling pathwaysNaoki Katase, Shin-Ichiro Nishimatsu, Akira Yamauchi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 26, 2018
[Introduction]Yoshiyuki Yamaguchi, Yosuke Katata, Makoto Okawaki, et al.
Pageof 9